rs104886192

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 3P and 12B. PM1PP2BP4_StrongBS1BS2

The NM_033380.3(COL4A5):​c.2692A>G​(p.Met898Val) variant causes a missense change. The variant allele was found at a frequency of 0.000221 in 1,203,910 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 85 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M898I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., 8 hem., cov: 23)
Exomes 𝑓: 0.00022 ( 0 hom. 77 hem. )

Consequence

COL4A5
NM_033380.3 missense

Scores

5
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:3U:1B:7

Conservation

PhyloP100: 5.54

Publications

5 publications found
Variant links:
Genes affected
COL4A5 (HGNC:2207): (collagen type IV alpha 5 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Mutations in this gene are associated with X-linked Alport syndrome, also known as hereditary nephritis. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Aug 2010]
COL4A5 Gene-Disease associations (from GenCC):
  • Alport syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P, ClinGen
  • X-linked Alport syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Myriad Women’s Health

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

PM1
In a hotspot region, there are 12 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 4 uncertain in NM_033380.3
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 538 curated pathogenic missense variants (we use a threshold of 10). The gene has 138 curated benign missense variants. Gene score misZ: 2.4995 (below the threshold of 3.09). Trascript score misZ: NaN (below the threshold of 3.09). GenCC associations: The gene is linked to X-linked Alport syndrome, Alport syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.053881973).
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000196 (22/112245) while in subpopulation SAS AF = 0.00147 (4/2714). AF 95% confidence interval is 0.000503. There are 0 homozygotes in GnomAd4. There are 8 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 8 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_033380.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A5
NM_033380.3
MANE Select
c.2692A>Gp.Met898Val
missense
Exon 32 of 53NP_203699.1P29400-2
COL4A5
NM_000495.5
c.2692A>Gp.Met898Val
missense
Exon 32 of 51NP_000486.1P29400-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A5
ENST00000328300.11
TSL:1 MANE Select
c.2692A>Gp.Met898Val
missense
Exon 32 of 53ENSP00000331902.7P29400-2
COL4A5
ENST00000483338.1
TSL:1
c.1516A>Gp.Met506Val
missense
Exon 16 of 20ENSP00000495685.1Q49AM6
COL4A5
ENST00000949143.1
c.2692A>Gp.Met898Val
missense
Exon 32 of 51ENSP00000619202.1

Frequencies

GnomAD3 genomes
AF:
0.000196
AC:
22
AN:
112245
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000324
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00339
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00147
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000150
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000304
AC:
55
AN:
181177
AF XY:
0.000425
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00324
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000186
Gnomad OTH exome
AF:
0.000225
GnomAD4 exome
AF:
0.000224
AC:
244
AN:
1091665
Hom.:
0
Cov.:
28
AF XY:
0.000215
AC XY:
77
AN XY:
357385
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26311
American (AMR)
AF:
0.00
AC:
0
AN:
35170
Ashkenazi Jewish (ASJ)
AF:
0.00326
AC:
63
AN:
19333
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30151
South Asian (SAS)
AF:
0.000856
AC:
46
AN:
53724
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40486
Middle Eastern (MID)
AF:
0.000243
AC:
1
AN:
4119
European-Non Finnish (NFE)
AF:
0.000137
AC:
115
AN:
836514
Other (OTH)
AF:
0.000414
AC:
19
AN:
45857
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
8
16
25
33
41
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000196
AC:
22
AN:
112245
Hom.:
0
Cov.:
23
AF XY:
0.000233
AC XY:
8
AN XY:
34395
show subpopulations
African (AFR)
AF:
0.0000324
AC:
1
AN:
30864
American (AMR)
AF:
0.00
AC:
0
AN:
10587
Ashkenazi Jewish (ASJ)
AF:
0.00339
AC:
9
AN:
2655
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3569
South Asian (SAS)
AF:
0.00147
AC:
4
AN:
2714
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6195
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
240
European-Non Finnish (NFE)
AF:
0.000150
AC:
8
AN:
53231
Other (OTH)
AF:
0.00
AC:
0
AN:
1503
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000444
Hom.:
6
Bravo
AF:
0.000151
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.000297
AC:
36

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
1
2
X-linked Alport syndrome (5)
-
-
3
not provided (3)
1
-
-
Autosomal dominant Alport syndrome (1)
-
-
1
COL4A5-related disorder (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.046
T
BayesDel_noAF
Uncertain
0.080
CADD
Benign
21
DANN
Benign
0.97
DEOGEN2
Uncertain
0.49
T
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.70
T
M_CAP
Benign
0.034
D
MetaRNN
Benign
0.054
T
MetaSVM
Benign
-0.57
T
MutationAssessor
Benign
0.45
N
PhyloP100
5.5
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-1.6
N
REVEL
Uncertain
0.47
Sift
Benign
0.21
T
Sift4G
Benign
0.60
T
Polyphen
0.0050
B
Vest4
0.17
MVP
0.99
MPC
0.30
ClinPred
0.051
T
GERP RS
4.5
Varity_R
0.26
gMVP
0.86
Mutation Taster
=62/38
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs104886192; hg19: chrX-107865047; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.